RBC Capital lowered the firm’s price target on Petco to $7 from $10 but keeps an Outperform rating on the shares after its Q2 results. The firm believes that the company is close to an inflection on two headwinds that have been weighing on shares – discretionary softness and variable rate debt exposure – but also believes that it is prudent to keep its estimates conservative, the analyst tells investors in a research note.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on WOOF:
- Petco price target lowered to $7 from $11 at Wells Fargo
- Petco price target lowered to $8 from $11 at Baird
- Petco Healthcare (NASDAQ: WOOF) Stumbles after Q2 Earnings Drop 62.5%, Future Projections Disappoint
- Petco falls 8% to $6.00 after cutting FY23 EPS guidance
- Petco Health + Wellness Company, Inc. Reports Second Quarter Earnings